DeepMed Research

Radboud University Medical Center

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1951-01-01

Employees: -

Market Cap: -

Website: http://www.radboudumc.nl

Clinical Trials

Inspiratory Muscle Training in Nemaline Myopathy

Not Applicable

Completed

Conditions: Inspiratory Muscle Training
Nemaline Myopathy

Interventions: Device: Threshold IMT, Philips Respironics, Murrysville, PA, USA

First Posted Date: 2018-11-02

Last Posted Date: 2024-12-05

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 42

Registration Number: NCT03728803

Locations: 🇳🇱
Radboud university medical center, Nijmegen, Netherlands

Bilateral TMS vs. Unilateral TMS

Not Applicable

Conditions: Orofacial Pain
Neuropathic Pain
Trigeminal Neuropathy

Interventions: Device: Transcranial magnetic stimulation

First Posted Date: 2018-10-18

Last Posted Date: 2018-10-18

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 12

Registration Number: NCT03710967

Locations: 🇳🇱
Radboud University, Nijmegen, Gelderland, Netherlands

Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin

Phase 1

Conditions: Gastrointestinal Cancer
Colorectal Cancer
Neoplasms
Peritoneal Carcinomatosis
Carcinoma

Interventions: Drug: Indium-111-DOTA-Labetuzumab-IRDye800CW injection
Radiation: SPECT/CT scan
Procedure: CRS extended with dual-modality imaging

First Posted Date: 2018-10-09

Last Posted Date: 2019-09-13

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 29

Registration Number: NCT03699332

Locations: 🇳🇱
Radboudumc, Nijmegen, Netherlands

PreColo Practice Variation

Terminated

Conditions: Postoperative Complications
Colon Cancer
Aging

First Posted Date: 2018-09-24

Last Posted Date: 2019-09-13

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 20

Registration Number: NCT03682133

Locations: 🇳🇱
Gelre ziekenhuizen, Apeldoorn, Gelderland, Netherlands
🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands

Dose Individualization of Pemetrexed - IMPROVE-I

Phase 4

Completed

Conditions: Non Small Cell Lung Cancer
Mesothelioma

Interventions: Drug: Pemetrexed + oral folinic acid rescue

First Posted Date: 2018-09-04

Last Posted Date: 2024-12-17

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 6

Registration Number: NCT03656549

Locations: 🇳🇱
Catharina hospital, Eindhoven, Netherlands
🇳🇱
Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands
🇳🇱
Antoni van Leeuwenhoek, Amsterdam, Netherlands

and more 3 locations

Dose Individualization of Pemetrexed - IMPROVE-III

Phase 4

Completed

Conditions: Non Small Cell Lung Cancer
Mesothelioma

Interventions: Drug: Pemetrexed

First Posted Date: 2018-08-31

Last Posted Date: 2022-05-10

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 10

Registration Number: NCT03655834

Locations: 🇳🇱
Antoni van Leeuwenhoek, Amsterdam, Netherlands
🇳🇱
Maastricht University Medical centre, Maastricht, Netherlands
🇳🇱
Radboud university medical centre, Nijmegen, Netherlands

and more 2 locations

Dose Individualization of Pemetrexed - IMPROVE-II

Phase 4

Terminated

Conditions: Non Small Cell Lung Cancer
Mesothelioma

Interventions: Drug: Pemetrexed

First Posted Date: 2018-08-31

Last Posted Date: 2022-05-13

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 81

Registration Number: NCT03655821

Locations: 🇳🇱
Maastricht University Medical centre, Maastricht, Netherlands
🇳🇱
Radboud university medical centre, Nijmegen, Netherlands
🇳🇱
Erasmus University Medical Centre, Rotterdam, Netherlands

and more 2 locations

Nationwide Implementation of Standardized Structured Reporting

Conditions: Standardized Structured Reporting

Interventions: Behavioral: Implementation tools

First Posted Date: 2018-08-28

Last Posted Date: 2018-08-28

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 50

Registration Number: NCT03649126

Locations: 🇳🇱
Radboud University Nijmegen Medical Center, Nijmegen, Gelderland, Netherlands

Response of Immune System to Flu Vaccination in PHTS

Not Applicable

Conditions: PTEN Hamartoma Tumor Syndrome

Interventions: Biological: Influvac Tetra

First Posted Date: 2018-08-15

Last Posted Date: 2018-08-15

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 30

Registration Number: NCT03630523

PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer

Recruiting

Conditions: Endometrial Cancer Recurrent
Endometrial Cancer Stage III
Endometrial Cancer Stage IV

Interventions: Drug: Hormonal Antineoplastics

First Posted Date: 2018-08-09

Last Posted Date: 2023-01-18

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 150

Registration Number: NCT03621904

Locations: 🇳🇱
Radboudumc, Nijmegen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy